Form D · Other Health Care
DECIMMUNE THERAPEUTICS INC
Cambridge, MA · CIK 0001376644
Offering snapshot reported Jan 16, 2013 · SEC filing
- Reported sold
- $1.75M Offering amount: $2.25M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 3, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 16, 2013 | Initial | $1,749,999 | No comparison | 3 | SEC filing |
| Sep 17, 2010 | Initial | $1,064,938 | No comparison | 3 | SEC filing |
| Sep 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-190385
The Issuer sold 2,916,666 shares of its Series A Convertible Redeemable Preferred Stock, par value $0.001 per share and intends to sell an additional 833,333 shares
Source: Form D, filed Jan 16, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael C. Carroll, Ph.D. | Director |
| Richard S. Foemmel, Ph.D. | Director |
| Lewis J. Geffen | Executive |
| Christopher K. Mirabelli, Ph.D. | Director, Executive |
| Janis C. Naeve, Ph.D. | Director |
| Harold R. Werner | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Healthcare Ventures 47 Thorndike St. Suite B1 1
Cambridge, MA, 02141
Cambridge, MA, 02141